Omics Core receives significant NIAAA funding

The Omics Core has received significant NIAAA funding for its continuing research.  Congratulations to Dr. Michael Merchant and colleagues at UofL and University of Pittsburgh on their new 5-year NIH R01 (R01AA028436, Biomarkers of Alcoholic Hepatitis) which continues their collaborations in this important area.  Our Omics investigators are leaders in their areas.